Biggest News Aggregation in the World
📰 Human Longevity News

Page 13 - Human Longevity News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from Human Longevity. Real-time updates on events, politics, business and more.

Epigenetic age acceleration could be used as a biomarker to estimate functional and cognitive aging

A first-of-its-kind study of 1,813 older women suggests that the accelerated biological aging of the body -; epigenetic age acceleration specifically -; is associated with lower odds of living to be 90 years old and also being physically mobile and having intact mental function.
United States Apurva Jain Andrea Lacroix Emily Henderson Women Health Initiative Herbert Wertheim School Of Public Health

Stay Updated with Latest News

Get breaking news updates delivered to your inbox

Browse All News →

JZZ Technologies, Inc. Launches ActiveLifestyleNutrition.com Product Site Offering Nutritional Solutions Aligned with Seniors' Needs

Anderson, South Carolina--(Newsfile Corp. - July 14, 2022) - JZZ Technologies Inc. (OTC Pink: JZZI) ("JZZ" or the "Company"), a diversified technology company focused on digital media and strategic biotechnology
United States Kostenloser Wertpapierhandel Charles Cardona View Research Technologies Inc Carolina Newsfile Corp

Deep Longevity Launched a Free Self-help Application, FuturSelf, Powered by Research Conducted with Harvard Medical School, on Optimizing Future Well-being with Artificial Intelligence

HONG KONG, June 21, 2022 /PRNewswire/ -- Endurance RP Limited's ("Endurance Longevity" or the "Company" and together with its subsidiaries, the "Group"; stock code: 0575.HK) wholly owned subsidiary Deep Longevity, Inc, a leading provider of deep biomarkers of aging and longevity is pleased to announceits collaboration with Dr. Nancy Etcoff of Harvard Medical School. Dr. Etcoff is widely recognized in the field of psychology and is a member of the Harvard Univers...
Hong Kong Harvard University United States Jamie Gibson Nancy Etcoff Vadim Gladyshev

Human Longevity strikes a SPAC deal to go public and fuel U.S., global expansion

Human Longevity, Inc., a startup founded by genomics pioneer J. Craig Venter, plans to join the public markets via a SPAC merger. If the business combination closes, HLI would receive about $345 million for continued commercialization of its platform that uses genomics, AI, and other technologies for early disease detection and other strategies intended to help people live longer.
J Craig Venter Amicus Therapeutics York Stock Exchange Freedom Acquisitioni Corporation New York Stock Exchange Human Longevity Inc

Explore More Categories

World News India News Business Technology Sports Entertainment Health Science